Company Filing History:
Years Active: 2004-2023
Title: The Innovative Journey of Samuel Wright
Introduction
Samuel Wright, hailing from Westfield, NJ, has made significant contributions to the field of biomedical research through his innovative inventions. With a total of six patents to his name, Wright's work primarily focuses on formulations that aim to improve healthcare outcomes. His pioneering efforts in the area of high-density lipoprotein (HDL) formulations have set new standards in cardiovascular disease treatment.
Latest Patents
Among Samuel Wright's notable inventions is his latest patent, which entails a reconstituted high-density lipoprotein formulation and its production method. This groundbreaking formulation boasts relatively low toxicity, making it safer for human administration. It comprises an apolipoprotein such as ApoAI or a fragment thereof, a lipid, and a detergent used at levels between 5-50% of those that would typically cause liver toxicity. With the lipid optimal at phosphatidylcholine in the range of 30-50 g/L, the molar ratio of apolipoprotein to lipid is ideally set between 1:40 and 1:75. This innovative formulation is aimed at treating various diseases including cardiovascular disease, hypercholesterolaemia, hypocholesterolaemia, acute coronary syndrome, atherosclerosis, and myocardial infarction.
Career Highlights
Samuel Wright has had an illustrious career, contributing his expertise to respected organizations such as CSL Limited and Merck & Company, Inc. His work has truly left an indelible mark in the pharmaceutical and biomedical sectors, particularly in the development of therapeutic compounds that have the potential to enhance patient care.
Collaborations
Throughout his career, Wright has collaborated with esteemed professionals in the field, including Martin A. Imboden and Reinhard Franz Bolli. These partnerships have fostered a synergistic approach to research and innovation, further enhancing the efficacy and application of his inventions.
Conclusion
Samuel Wright's dedication to innovation within the biomedical field showcases the impact that a single inventor can have on healthcare. His latest patent regarding high-density lipoprotein formulations not only contributes to advancing medical science but also emphasizes the importance of research collaboration. As he continues to push the boundaries of invention, Wright remains a valuable asset to the scientific community and a beacon of innovation.